Show/hide main menu

News

News Highlights

King's joins AllTrials campaign

Posted on 02/05/2014
test-tube-puff

King’s College London has become the second London university and third university in the UK to fully sign up to the AllTrials initiative.

The AllTrials campaign, launched in January 2013, calls for all clinical trials to be registered and their results reported. The campaign has published a detailed plan on how such trials can be registered and the results reported. 

Departments and centres from a number of universities have joined the campaign, but King’s is only the second London university to sign up on behalf of the whole organisation.

Professor Sir Robert Lechler, Vice-Principal (Health) at King’s College London said: 'King's College London is delighted to support the AllTrials initiative and applauds the attention that has been drawn to the importance of ensuring that all clinical trial results are published.  Inevitably, there will be historic unpublished trials conducted by most public sector organisations but King's College London is strongly encouraging all investigators to register their clinical trials, and is committed to publishing results from all current and future clinical trials, irrespective of outcome.'

Professor Andrew Pickles, Director of the King's Clinical Trials Unit, said: 'I am delighted that the College is supporting this initiative, which should increase the information available to help us determine the best treatments and medicines to prescribe to patients. We will all benefit from the publication of all clinical trial results.'

Síle Lane, Director of Campaigns at Sense About Science, said: 'We are pleased that King's College London has joined AllTrials and is encouraging its researchers to ensure all their clinical trials are registered. Universities and institutions are going to have a huge role in helping and encouraging their researchers to be more transparent. We encourage all UK universities to follow the lead set by King's, London School of Hygiene and Tropical Medicine and Cardiff University and join the campaign.'

King’s researchers seeking more information should contact Caroline Murphy, Operational Director at the King's Clinical Trials Unit on 0207 848 5273/0532 or caroline.murphy@kcl.ac.uk.

Notes to editors

For further information please contact Jenny Gimpel, PR Manager (Health), on 0207 848 4334 or jenny.gimpel@kcl.ac.uk

For further information about King's visit the 'King's in Brief' pages

More information about the AllTrials campaign can be found here.


News Highlights:

News Highlights...RSS FeedAtom Feed

Modi: Re-defining Indian politics?

Modi: Re-defining Indian politics?

Description
A panel of experts considered the implications of the unprecedented Indian election victory of the Hindu nationalist BJP led by Narendra Modi in a lively event hosted by King's India Institute.
Epidarex Capital invests in UK Life Sciences

Epidarex Capital invests in UK Life Sciences

Description
Epidarex Capital, a leading international venture capital firm, has raised over £47.5 million to lead investments in early-stage life science and health technology companies, including spin-outs from leading research universities. King's College London invested in the final closing.
King's experts at the 2014 Cheltenham Science Festival

King's experts at the 2014 Cheltenham Science Festival

Description
Academics from across King's will feature at the Times Cheltenham Science Festival this year, giving talks and hosting events on a variety of topics between 3 and 8 June including doping and sport, personalised medicine and even the science of cake.
Sitemap Site help Terms and conditions  Privacy policy  Accessibility  Modern slavery statement  Contact us

© 2018 King's College London | Strand | London WC2R 2LS | England | United Kingdom | Tel +44 (0)20 7836 5454